Alpa Laboratories Limited (BOM:532878)
India · Delayed Price · Currency is INR 59.00
-0.09 (-0.15%)
At close: Oct 6, 2026
Alpa Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,106 | 1,058 | 1,125 | 1,087 | 929.55 | 1,123 | |
Revenue Growth | 0.46% | -5.91% | 3.42% | 16.98% | -17.20% | 15.08% |
Cost of Revenue | 823.75 | 743.02 | 760.44 | 746.04 | 616.67 | 761.06 |
Gross Profit | 282.55 | 315.07 | 364.08 | 341.35 | 312.89 | 361.61 |
Selling, General & Admin | 163.1 | 164.28 | 149.55 | 156.15 | 125.47 | 122.82 |
Other Operating Expenses | 130.35 | 117.9 | 167.08 | 99.08 | 106.51 | 132.16 |
Operating Expenses | 316.04 | 303.09 | 338.65 | 274.77 | 245.27 | 271.55 |
Operating Income | -33.49 | 11.98 | 25.43 | 66.58 | 67.62 | 90.06 |
Interest Expense | -3.21 | -0.09 | -0.29 | -3.59 | -0.83 | -1.07 |
Interest & Investment Income | - | 27.09 | 24.11 | 25.63 | 12.3 | 15.27 |
Earnings From Equity Investments | - | - | - | - | -0 | 0.07 |
Currency Exchange Gain (Loss) | - | 1.29 | 8.57 | 7.39 | 19.56 | 2.61 |
Other Non Operating Income (Expenses) | 95.8 | 7.06 | 0.57 | 20.47 | 27.41 | 0.36 |
EBT Excluding Unusual Items | 59.1 | 47.33 | 58.39 | 116.48 | 126.06 | 107.3 |
Gain (Loss) on Sale of Investments | - | 119.64 | 197.78 | 90.34 | 32.97 | 88.32 |
Gain (Loss) on Sale of Assets | - | - | 0.5 | - | -0.12 | - |
Pretax Income | 59.1 | 166.97 | 256.67 | 206.82 | 158.9 | 195.62 |
Income Tax Expense | 16.87 | 16.87 | 61.64 | 39.06 | 33.08 | 54.7 |
Net Income | 42.22 | 150.1 | 195.03 | 167.77 | 125.83 | 140.92 |
Net Income to Common | 42.22 | 150.1 | 195.03 | 167.77 | 125.83 | 140.92 |
Net Income Growth | -83.87% | -23.04% | 16.25% | 33.33% | -10.71% | 94.45% |
Shares Outstanding (Basic) | 20 | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 20 | 21 | 21 | 21 | 21 | 21 |
Shares Change | -4.17% | - | - | - | - | -0.00% |
EPS (Basic) | 2.11 | 7.13 | 9.27 | 7.97 | 5.98 | 6.70 |
EPS (Diluted) | 2.11 | 7.13 | 9.27 | 7.97 | 5.98 | 6.70 |
EPS Growth | -83.17% | -23.04% | 16.25% | 33.33% | -10.71% | 94.45% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 60.43 | 69.39 | -27.37 | 77.78 | 77.49 |
Free Cash Flow Per Share | - | 2.87 | 3.30 | -1.30 | 3.70 | 3.68 |
Gross Margin | 25.54% | 29.78% | 32.38% | 31.39% | 33.66% | 32.21% |
Operating Margin | -3.03% | 1.13% | 2.26% | 6.12% | 7.27% | 8.02% |
Profit Margin | 3.82% | 14.19% | 17.34% | 15.43% | 13.54% | 12.55% |
Free Cash Flow Margin | - | 5.71% | 6.17% | -2.52% | 8.37% | 6.90% |
EBITDA | -12.85 | 32.9 | 47.46 | 86.13 | 80.91 | 106.63 |
EBITDA Margin | -1.16% | 3.11% | 4.22% | 7.92% | 8.70% | 9.50% |
D&A For EBITDA | 20.64 | 20.92 | 22.02 | 19.55 | 13.29 | 16.57 |
EBIT | -33.49 | 11.98 | 25.43 | 66.58 | 67.62 | 90.06 |
EBIT Margin | -3.03% | 1.13% | 2.26% | 6.12% | 7.27% | 8.02% |
Effective Tax Rate | 28.55% | 10.11% | 24.02% | 18.88% | 20.82% | 27.96% |
Revenue as Reported | 1,202 | 1,216 | 1,358 | 1,236 | 1,023 | 1,230 |
Advertising Expenses | - | 4.1 | 4.88 | 22.53 | 3.11 | 2.77 |